TANAKA Sachiko 田中祥子

Researcher Number	50328556
Other IDs
Affiliation *help	2016 – 2018 : 東京薬科大学, 薬学部, 助教 2012 – 2014 : 東京薬科大学, 薬学部, 助教
Review Section/Research Field	Principal Investigator Medical pharmacy
Keywords	Principal Investigator 制御性B細胞 / B細胞活性化因子 / 免疫寛容 / カルシニューリン阻害剤 / オーダーメイド療法 / IL-10 / 重症筋無力症 / 重症筋無力症状 / 副腎皮質ステロイド剤 / CD24+CD38+CD19+制御性B細胞 / CD25+Foxp3+CD4+制御性T細胞

Induction of Peripheral immune tolerance in Myasthenia Gravis PatientsPrincipal Investigator
- Principal Investigator
  
  TANAKA Sachiko
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Tokyo University of Pharmacy and Life Science

All 2015 2014 2012 Other

All Journal Article Presentation

[Journal Article] 重症筋無力症患者におけるBAFFシグナル制御を標的とした新たな免疫抑制療法の可能性に関する検討2015
- Author(s)
  田中　祥子　井上　文増田　眞之　内海　裕也　平野　俊彦
- Journal Title
  
  臨床薬理の進歩
  
  Volume : 30 Pages : 60-64
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24590215
[Journal Article] 重症筋無力症患者における治療効果予測因子としての末梢T・Bリンパ球の特徴付け2014
- Author(s)
  田中　祥子
- Journal Title
  
  薬学研究の進歩　薬学研究奨励財団助成研究成果報告集
  
  Volume : 30 Pages : 95-102
- Data Source
  KAKENHI-PROJECT-24590215
[Presentation] 重症筋無力症患者における制御性B細胞と治療効果との関連2014
- Author(s)
  落合　有美香，田中　祥子，増田　眞之，近藤　智子，井上　文，伊藤　傑，明石　貴雄，相澤　仁志，杉山　健太郎，平野　俊彦
- Organizer
  日本薬学会第134年会
- Place of Presentation
  熊本
- Data Source
  KAKENHI-PROJECT-24590215
[Presentation] Low-dose glucocorticoid therapy complement the pituitary-adrenocortical system and reduce anxiety and insomnia in myasthenia gravis patients2012
- Author(s)
  Sachiko Tanaka, Takao Akashi,Suguru Itoh, Masayuki Masuda, Hiroya Utsumi, Chiho Kasahara, Yumika Ochiai, Mamiko Yamamoto, Hironori Takeuchi,　Sakae Unezaki and Toshihiko Hirano
- Organizer
  The 72th World Congress of Pharmacy and Pharmaceutical Sciences
- Place of Presentation
  Amsterdam, Holland
- Data Source
  KAKENHI-PROJECT-24590215
[Presentation] B cell activating factor belonging to the tumor necrosis family were related to efficacy of glucocorticoid therapy in myasthenia gravis patients2012
- Author(s)
  Sachiko Tanaka, Mamiko Yamamoto, Akemi Maeno, Yumika Ochiai, Suguru Ito, Masayuki Masuda, Kenji Onda, Kentaro Sugiyama, Hiroya Utsumi, Toshihiko Hirano
- Organizer
  The 33 rd the Annual Meating of the Japanese Society of Clinical Pharmacology and Therapeutics(BPS/JSCPT Joint Symposium)
- Place of Presentation
  Naha, Japan
- Data Source
  KAKENHI-PROJECT-24590215
[Presentation] 重症筋無力症患者における制御性B細胞と治療効果との関連
- Author(s)
  田中　祥子，増田　眞之，落合　有美香，河合　奈々江，黒江　里歌，井上　文，伊藤　傑，相澤　仁志，明石　貴雄，恩田　健二，杉山　健太郎，平野　俊彦
- Organizer
  第35回日本臨床薬理学会学術総会
- Place of Presentation
  愛媛県　松山市
- Year and Date
  2015-12-04 – 2015-12-06
- Data Source
  KAKENHI-PROJECT-24590215

1. MASUDA Masayuki

# of Collaborated Projects : 1results

# of Collaborated Products : 5results
2. INOUE Aya

# of Collaborated Projects : 1results

# of Collaborated Products : 3results
3. ITO Suguru

# of Collaborated Projects : 1results

# of Collaborated Products : 4results
4. AIZAWA Hitoshi

# of Collaborated Projects : 1results

# of Collaborated Products : 2results

TANAKA Sachiko 田中祥子

Research Projects

Research Products

Co-Researchers

Induction of Peripheral immune tolerance in Myasthenia Gravis PatientsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] 重症筋無力症患者におけるBAFFシグナル制御を標的とした新たな免疫抑制療法の可能性に関する検討2015

Author(s)

Journal Title

Data Source

[Journal Article] 重症筋無力症患者における治療効果予測因子としての末梢T・Bリンパ球の特徴付け2014

Author(s)

Journal Title

Data Source

[Presentation] 重症筋無力症患者における制御性B細胞と治療効果との関連2014

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] Low-dose glucocorticoid therapy complement the pituitary-adrenocortical system and reduce anxiety and insomnia in myasthenia gravis patients2012

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] B cell activating factor belonging to the tumor necrosis family were related to efficacy of glucocorticoid therapy in myasthenia gravis patients2012

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] 重症筋無力症患者における制御性B細胞と治療効果との関連

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

TANAKA Sachiko 田中 祥子

Research Projects

Research Products

Co-Researchers

Induction of Peripheral immune tolerance in Myasthenia Gravis PatientsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] 重症筋無力症患者におけるBAFFシグナル制御を標的とした新たな免疫抑制療法の可能性に関する検討2015

Author(s)

Journal Title

Data Source

[Journal Article] 重症筋無力症患者における治療効果予測因子としての末梢T・Bリンパ球の特徴付け2014

Author(s)

Journal Title

Data Source

[Presentation] 重症筋無力症患者における制御性B細胞と治療効果との関連2014

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] Low-dose glucocorticoid therapy complement the pituitary-adrenocortical system and reduce anxiety and insomnia in myasthenia gravis patients2012

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] B cell activating factor belonging to the tumor necrosis family were related to efficacy of glucocorticoid therapy in myasthenia gravis patients2012

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] 重症筋無力症患者における制御性B細胞と治療効果との関連

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

TANAKA Sachiko 田中祥子